KCNQ2 Encephalopathy and Effect of Early Treatment on the Clinical Phenotype

Affiliations

¹ Department of Pediatric Neurology and In-Charge Child Development Clinic, KAHER's J N Medical College, Belagavi, Karnataka State, India.
² Department of Paediatrics, KAHER's J N Medical College, Belagavi, Karnataka State, India.
³ Department of Child Development Centre, KLES PK Hospital, Belagavi, Karnataka State, India.

Mahesh Kamate et al. Ann Indian Acad Neurol. 2022 Mar-Apr.

. 2022 Mar-Apr;25(2):289-291.

doi: 10.4103/aian.aian_335_21. Epub 2022 Jan 12.

¹ Department of Pediatric Neurology and In-Charge Child Development Clinic, KAHER's J N Medical College, Belagavi, Karnataka State, India.
² Department of Paediatrics, KAHER's J N Medical College, Belagavi, Karnataka State, India.
³ Department of Child Development Centre, KLES PK Hospital, Belagavi, Karnataka State, India.

No abstract available

Conflict of interest statement

There are no conflicts of interest.

1. Spagnoli C, Salerno GG, Iodice A, Frattini D, Pisani F, Fusco C. KCNQ2 encephalopathy: A case due to a de novo deletion. Brain Dev. 2018;40:65–8. - PubMed
1. Pisano T, Numis AL, Heavin SB, Weckhuysen S, Angriman M, Suls A, et al. Early and effective treatment of KCNQ2 encephalopathy. Epilepsia. 2015;56:685–91. - PubMed
1. Srivastava S, Sahin M. Autism spectrum disorder and epileptic encephalopathy: Common causes, many questions. J Neurodev Disord. 2017;9:23–34. - PMC - PubMed
1. Schubert-Bast S, Hofstetter P, Fischer D, Schloesser R, Ramantani G, Kieslich M. Sodium channel blockers in KCNQ2-encephalopathy: Lacosamide as a new treatment option. Seizure. 2017;51:171–3. - PubMed
1. Malerba F, Alberini G, Balagura G, Marchese F, Amadori E, Riva A, et al. Genotype-phenotype correlations in patients with de novo KCNQ2 pathogenic variants. Neurol Genet. 2020;6:e528. - PMC - PubMed